Vision Medicals
Guangzhou
About Vision Medicals
Vision Medicals is a provider of pathogenic gene diagnostic services, focusing on infection-precise medical treatment, high-throughput sequencing-based pathogen metagenomics and CRISPR-based rapid diagnosis and other new technologies, effectively improving the detection ability of clinical pathogens and shortening The reporting cycle accelerated the development of the infection-accurate medical industry. The company developed a pathogenic nucleic acid enrichment technology with independent intellectual property rights for the detection of pathogenic micronucleic acids in clinical samples. The pathogen macro was established through the accumulation of pathogen detection big data. Genomics intelligent analysis and reporting system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $119.9M
- Funding stage: Late Stage Venture
- Last round: Series D (May 2024)
- Website: visionmedicals.com
Industries & Categories
Health Care, Precision Medicine
Canonical: https://fsome.com/organization/vision-medicals-89022 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.